<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Am J Trop Med Hyg</journal-id>
      <journal-id journal-id-type="publisher-id">tpmd</journal-id>
      <journal-title-group>
        <journal-title>The American Journal of Tropical Medicine and Hygiene</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0002-9637</issn>
      <issn pub-type="epub">1476-1645</issn>
      <publisher>
        <publisher-name>The American Society of Tropical Medicine and Hygiene</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">20064985</article-id>
      <article-id pub-id-type="pmc">2803499</article-id>
      <article-id pub-id-type="doi">10.4269/ajtmh.2010.09-0490</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Images in Clinical Tropical Medicine</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Resolution of Cutaneous Old World and New World Leishmaniasis after Oral Miltefosine Treatment</article-title>
        <alt-title alt-title-type="left-running-head">TAPPE AND OTHERS</alt-title>
        <alt-title alt-title-type="right-running-head">MILTEFOSINE IN CUTANEOUS LEISHMANIASIS</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Tappe</surname>
            <given-names>Dennis</given-names>
          </name>
          <xref ref-type="corresp" rid="COR1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>M&#xFC;ller</surname>
            <given-names>Andreas</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stich</surname>
            <given-names>August</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="AFF1">Institute of Hygiene and Microbiology, University of W&#xFC;rzburg, W&#xFC;rzburg, Germany; Department of Tropical Medicine, Medical Mission Hospital, W&#xFC;rzburg, Germany</aff>
      <author-notes>
        <corresp id="COR1">*Address correspondence to Dennis Tappe, Institute of Hygiene and Microbiology, University of W&#xFC;rzburg, Josef-Schneider-Str.2, 97080 W&#xFC;rzburg, Germany. E-mail: <email>dtappe@hygiene.uni-wuerzburg.de</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>1</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <month>1</month>
        <year>2010</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <volume>82</volume>
      <issue>1</issue>
      <fpage>1</fpage>
      <lpage>3</lpage>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>8</month>
          <year>2009</year>
        </date>
        <date date-type="accepted">
          <day>28</day>
          <month>9</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The American Society of Tropical Medicine and Hygiene</copyright-statement>
        <copyright-year>2010</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
          <license-p>This is an Open Access article distributed under the terms of the American Society of Tropical Medicine and Hygiene's Re-use License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>An Afghan migrant who had returned from a visit to the Middle East 2 years before was seen with a non-healing painless lesion on the forearm (<xref ref-type="fig" rid="F1">Figure 1A</xref>). A skin biopsy showed intracellular <italic>Leishmania</italic> parasites in the subcutis (<xref ref-type="fig" rid="F1">Figure 1B</xref> and <xref ref-type="fig" rid="F1">C</xref>), and the polymerase chain reaction (PCR) was positive for <italic>Leishmania tropica</italic>. At the same time, a German traveler who had returned from a vacation to Central America 1 month before was seen with progressively ulcerating painless lesions on the ankle, thigh, and forearm (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Scarification of the lesions' margins showed sparse <italic>Leishmania</italic> amastigotes (<xref ref-type="fig" rid="F2">Figure 2B</xref> and <xref ref-type="fig" rid="F2">C</xref>) and the PCR from biopsies was positive for <italic>L</italic>. <italic>braziliensis</italic>. A 28-day treatment with oral miltefosine (2 mg and 2.5 mg/kg, respectively) was initiated in both individuals and the patients were seen at intervals of several weeks (<xref ref-type="fig" rid="F3">Figures 3</xref> and <xref ref-type="fig" rid="F4">4</xref>). All lesions healed, but both patients developed nausea and elevated liver function tests during pharmacotherapy. The highest values of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were 66 U/L and 44 U/L in the female migrant and 73 U/L and 33 U/L in the male traveler, respectively. Bilirubin levels were normal in both patients, but the male patient developed &#x3B3;GT levels of 113 U/L. All values returned to normal 2 and 3 weeks after the end of treatment, respectively. Neither patient's lesions showed clinical relapse when examined 4 months after the end of therapy. Miltefosine (hexadecylphosphocholine) has been shown to be effective in cutaneous and visceral leishmaniasis.<xref ref-type="bibr" rid="R1">1</xref> At least some strains of <italic>L. braziliensis</italic>, a species that can cause both cutaneous and mucocutaneous disease in the New World, have demonstrated a decreased sensitivity to the drug <italic>in vitro</italic>, however.<xref ref-type="bibr" rid="R2">2</xref></p>
    <fig id="F1" position="float">
      <label>Figure 1.</label>
      <caption>
        <p>Cutaneous Old World leishmaniasis caused by <italic>Leishmania tropica</italic> in an Afghan woman. <bold>A</bold>, Initial presentation of the dry, plaque-like lesion with central nodule on the forearm. <bold>B</bold>, Intracellular parasites in vacuoles of a giant cell (arrowheads). Haematoxylin and eosin stain, magnification &#xD7;1,000. <bold>C</bold>, <italic>Leishmania</italic> in macrophages (arrowheads). Haematoxylin and eosin stain, magnification &#xD7;1,000. This figure appears in color at <ext-link ext-link-type="uri" xlink:href="www.ajtmh.org">www.ajtmh.org</ext-link>.</p>
      </caption>
      <graphic xlink:href="tropmed-82-001-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Figure 2.</label>
      <caption>
        <p>Cutaneous New World leishmaniasis caused by <italic>Leishmania braziliensis</italic> in a German traveler after a vacation in Costa Rica and Belize. <bold>A</bold>, Initial presentation of the wet ulcerated lesion on the ankle (upper row), thigh (middle row), and forearm (lower row). Lesions were superinfected with Panton Valentine leukocidin-negative <italic>Staphylococcus aureus</italic>, <italic>Escherichia coli</italic>, and viridans streptococci. <bold>B</bold>, Extracellular <italic>Leishmania</italic> amastigote in tissue scarification. Giemsa stain, magnification &#xD7;1,000. <bold>C</bold>, Intracellular parasite in a monocyte (arrowhead). Giemsa stain, magnification &#xD7;1,000. This figure appears in color at <ext-link ext-link-type="uri" xlink:href="www.ajtmh.org">www.ajtmh.org</ext-link>.</p>
      </caption>
      <graphic xlink:href="tropmed-82-001-g002"/>
    </fig>
    <fig id="F3" position="float">
      <label>Figure 3.</label>
      <caption>
        <p>Follow-up presentation of Old World cutaneous leishmaniasis. <bold>A</bold>, Increasing local inflammation 14 days after start of miltefosine treatment. The lesion looks more nodular than before treatment. <bold>B</bold>, Decreasing inflammation 21 days after start of pharmacotherapy. <bold>C</bold>, Resolution of lesion 4 weeks after the end of treatment. Repeated <italic>Leishmania</italic> serology remained negative throughout the observation period in this patient. This figure appears in color at <ext-link ext-link-type="uri" xlink:href="www.ajtmh.org">www.ajtmh.org</ext-link>.</p>
      </caption>
      <graphic xlink:href="tropmed-82-001-g003"/>
    </fig>
    <fig id="F4" position="float">
      <label>Figure 4.</label>
      <caption>
        <p>Follow-up presentation of New World cutaneous leishmaniasis. <bold>A</bold>, Inflammatory accentuation of the lesions' ring walls 2 weeks after start of miltefosine treatment. <bold>B</bold>, Wounds are nearly fully covered by scar tissue 3 weeks after cessation of miltefosine therapy. <bold>C</bold>, Resolution of lesions 7 weeks after the end of treatment. Upper row, lesion on the ankle; middle row, lesion on the thigh; lower row, lesion on the forearm. <italic>Leishmania</italic> immunoblot was positive in this patient at initial presentation. This figure appears in color at <ext-link ext-link-type="uri" xlink:href="www.ajtmh.org">www.ajtmh.org</ext-link>.</p>
      </caption>
      <graphic xlink:href="tropmed-82-001-g004"/>
    </fig>
  </body>
  <back>
    <ref-list>
      <ref id="R1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berman</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <year>2008</year>
          <article-title>Treatment of leishmaniasis with miltefosine: 2008 status</article-title>
          <source>Expert Opin Drug Metab Toxicol</source>
          <volume>4</volume>
          <fpage>1209</fpage>
          <lpage>1216</lpage>
          <pub-id pub-id-type="pmid">18721114</pub-id>
        </mixed-citation>
      </ref>
      <ref id="R2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S&#xE1;nchez-Ca&#xF1;ete</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>P&#xE9;rez-Victoria</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Gamarro</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Castanys</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <year>2009</year>
          <article-title>Low plasma membrane expression of the miltefosine transport complex renders <italic>Leishmania braziliensis</italic> refractory to the drug</article-title>
          <source>Antimicrob Agents Chemother</source>
          <volume>53</volume>
          <fpage>1305</fpage>
          <lpage>1313</lpage>
          <pub-id pub-id-type="pmid">19188379</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
    <fn-group>
      <fn id="FN1">
        <p>Authors' addresses: Dennis Tappe, Institute of Hygiene and Microbiology, University of W&#xFC;rzburg, W&#xFC;rzburg, Germany and Department of Tropical Medicine, Medical Mission Hospital, W&#xFC;rzburg, Germany, E-mail: <email>dtappe@hygiene.uni-wuerzburg.de</email>. Andreas M&#xFC;ller and August Stich, Department of Tropical Medicine, Medical Mission Hospital, W&#xFC;rzburg, Germany, E-mails: <email>andreasmueller@missioklinik.de</email> and <email>stich@missioklinik.de</email>.</p>
      </fn>
    </fn-group>
  </back>
</article>
</pmc-articleset>
